Cargando…

Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment

INTRODUCTION: Lately, the use of biological therapy in various autoimmune diseases is increasing. The ideal marker for monitoring the effects of modern therapy is still non-existent. AIM: To investigate early response biomarkers of SLE and RA patients under the rituximab treatment are in research ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zecevic, Lamija, Mekic, Mevludin, Subasic, Djemo, Hadziabulic, Majda, Isak, Edmira, Subasic, Emina, Selmanovic, Kenan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Medical Sciences of Bosnia and Herzegovina 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007611/ https://www.ncbi.nlm.nih.gov/pubmed/32082002 http://dx.doi.org/10.5455/medarh.2019.73.374-377

Ejemplares similares

Whose Issue Is It Anyway? The Effects of Leader Gender and Equality Message Framing on Men’s and Women’s Mobilization Toward Workplace Gender Equality
por: Hardacre, Stephanie L., et al.
Publicado: (2018)

Anti–Cyclic Citrullinated Peptide Antibody as a Predictor of Rheumathoid Arthritis Complications
por: Mekic, Mevludin, et al.
Publicado: (2020)

Evaluation of Drug Treatment of Bronchopneumonia at the Pediatric Clinic in Sarajevo
por: Zec, Svjetlana Loga, et al.
Publicado: (2016)

Relation Between Anti-CCP Antibodies and Sharp Score in Rheumatoid Arthritis
por: Mekic, Mevludin, et al.
Publicado: (2020)

The Increased Ratio of Blood CD56(bright) NK to CD56(dim) NK Is a Distinguishing Feature of Primary Sjögren's Syndrome
por: Ming, Bingxia, et al.
Publicado: (2020)

UTILISATION ANALYSIS OF ANTIHYPERTENSIVE DRUGS IN BOSNIA AND HERZEGOVINA FOR THE TIME-PERIOD 2013–2015
por: Selmanovic, Kenan, et al.
Publicado: (2016)

Potential Immune Biomarkers in Diagnosis and Clinical Management for Systemic Lupus Erythematosus
por: Zecevic, Lamija, et al.
Publicado: (2018)

ELISA Test for Analyzing of Incidence of Type 1 Diabetes Autoantibodies (GAD and IA2) in Children and Adolescents
por: Delic-Sarac, Marina, et al.
Publicado: (2016)

The Impact of School Climate and School Identification on Academic Achievement: Multilevel Modeling with Student and Teacher Data
por: Maxwell, Sophie, et al.
Publicado: (2017)

Reduction of the CD16(−)CD56(bright) NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer
por: Koo, Kyo Chul, et al.
Publicado: (2013)

Loss of CCR7 Expression on CD56(bright) NK Cells Is Associated with a CD56(dim)CD16(+) NK Cell-Like Phenotype and Correlates with HIV Viral Load
por: Hong, Henoch S., et al.
Publicado: (2012)

NK cells CD56(bright) and CD56(dim) subset cytokine loss and exhaustion is associated with impaired survival in myeloma
por: Seymour, Frances, et al.
Publicado: (2022)

CD4/CD8 Ratio as a Predictor for the Occurrence of Metabolic Syndrome in HIV / AIDS Patients During 6 Months of cART Therapy
por: Gojak, Refet, et al.
Publicado: (2019)

CD56(dim)CD16(dim) Natural Killer (NK) Cells: The Forgotten Population
por: Zimmer, Jacques
Publicado: (2020)

Financial Aspects and the Future of the Pharmaceutical Industry in the United States of America
por: Karamehic, Jasenko, et al.
Publicado: (2013)

SLE - Rituximab in lupus
por: Eisenberg, Robert
Publicado: (2003)

Oncolytic virus treatment differentially affects the CD56(dim) and CD56(bright) NK cell subsets in vivo and regulates a spectrum of human NK cell activity
por: Wantoch, Michelle, et al.
Publicado: (2022)

CD56 regulates human NK cell cytotoxicity through Pyk2
por: Gunesch, Justin T, et al.
Publicado: (2020)

CD56(neg)CD16(+) NK cells are activated mature NK cells with impaired effector function during HIV-1 infection
por: Milush, Jeffrey M, et al.
Publicado: (2013)

CD4+CD56+ Lineage Negative Hematopoietic Neoplasm : So Called Blastic NK Cell Lymphoma
por: Kim, Yoonjung, et al.
Publicado: (2005)

The frequencies of peripheral blood CD5(+)CD19(+) B cells, CD3(−)CD16(+)CD56(+) NK, and CD3(+)CD56(+) NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder
por: Khani, Leila, et al.
Publicado: (2022)

Ageing is associated with a decline in peripheral blood CD56(bright )NK cells
por: Chidrawar, Shivani M, et al.
Publicado: (2006)

Circulating CD56(bright) NK cells inversely correlate with survival of melanoma patients
por: de Jonge, Kaat, et al.
Publicado: (2019)

Identification and Functional Analysis of Human CD56(neg) NK Cells by Flow Cytometry
por: Orrantia, Ane, et al.
Publicado: (2020)

Alveolar Rhabdomyosarcoma with CD 56 Positivity: A Mimic of Extranodal NK/T Cell Lymphoma
por: Kumar, Uma, et al.
Publicado: (2022)

Regulation of Development of CD56(bright)CD11c(+) NK-like Cells with Helper Function by IL-18
por: Li, Wen, et al.
Publicado: (2013)

Enriched CD45RA(−)CD62L(+) central memory T and decreased CD3(+)CD56(+) natural killer T lymphocyte subsets in the rectum of ulcerative colitis patients
por: Iwamuro, Masaya, et al.
Publicado: (2022)

Alterations in the CD56(−) and CD56(+) T Cell Subsets during COVID-19
por: Vavilova, Julia D., et al.
Publicado: (2023)

Analysis of the Characteristics of TIGIT-Expressing CD3(−)CD56(+)NK Cells in Controlling Different Stages of HIV-1 Infection
por: Zhang, Xin, et al.
Publicado: (2021)

Comprehensive Analyses of Type 1 Diabetes Ketosis- or Ketoacidosis-Related Genes in Activated CD56(+)CD16(+) NK Cells
por: Shi, Ruifeng, et al.
Publicado: (2021)

Functional TRPA1 Channels Regulate CD56(dim)CD16(+) NK Cell Cytotoxicity against Tumor Cells
por: Scopelliti, Fernanda, et al.
Publicado: (2023)

Primary CD56-positive NK/T-cell lymphoma of median nerve: a case report.
por: Kim, J., et al.
Publicado: (1998)

CD56-Negative Extranodal NK/T-Cell Lymphoma, Nasal Type, with Extranasal Cutaneous Involvement
por: Kim, Hee Joo, et al.
Publicado: (2015)

Human NK cell development requires CD56-mediated motility and formation of the developmental synapse
por: Mace, Emily M., et al.
Publicado: (2016)

Circulating CD56+ NKG2D+ NK cells and postoperative fertility in ovarian endometrioma
por: Liu, Zhi-Qin, et al.
Publicado: (2020)

Immune Dysfunctions of CD56(neg) NK Cells Are Associated With HIV-1 Disease Progression
por: Cao, Wen-Jing, et al.
Publicado: (2022)

The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56(bright) NK cells
por: Ziegler, Annerose E., et al.
Publicado: (2023)

Enrichment of CD56(dim)KIR+CD57+ highly cytotoxic NK cells in tumor infiltrated lymph nodes of melanoma patients
por: Ali, Talib Hassan, et al.
Publicado: (2014)

A New Hope for CD56(neg)CD16(pos) NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases
por: Forconi, Catherine S., et al.
Publicado: (2020)

Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56(bright)CD16(−) subset
por: Veneziani, Irene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_38o6d9ldp84jb5pdtujpf667g2